FDA Oks marketing of first AI device used to detect lesions during colonoscopy
The US Food and Drug Administration (FDA) recently approved the marketing of the GI Genius, a system that is uses artificial intelligence (AI) technology to aid in the detection of potentially cancerous polyps during a colonoscopy. During a colonoscopy, the technology highlights portions of interest of the colon and generate...
CONTINUE READING
Foods that Fight Cancer: Recipe Videos
We've posted some new recipe videos on our sister site, Foods that Fight Cancer! Produced by a nutritionist CCC patient support specialist Chana Cohen, in partnership with ELLICSR Kitchen, these videos offer instructions for easy, delicious meals designed with your health in mind. Watch the videos, try out the recipes, and be...
CONTINUE READING
OICR Translational Research Conference
The Ontario Cancer Research Institute (OICR) held a conference on Translational Research in Ontario on March 25th and 26th. The CCC had the opportunity to make a poster presentation entitled: A Stakeholder Charter for Patient and Patient Group and Patient Group Engagement in Cancer Clinical Trials. The authors of this projec...
CONTINUE READING
Addressing cancer disparities in Canada
April is Diversity Month dedicated to celebrating and honouring all individuals that make up our community. From a health care perspective, acknowledging diversity is to address race/ethnicity, sex, gender identity, age, income, education, and geographic location as important factors that contribute to a person’s ability to ...
CONTINUE READING
The role of maintenance strategies in metastatic colorectal cancer
Results from a systematic review published in JAMA Oncology found that maintenance chemotherapy following initial chemotherapy appeared to be more beneficial for patients with metastatic colorectal cancer (mCRC) than continuing a full induction chemotherapy regimen until disease progression. Systematic review: a review of...
CONTINUE READING
